Meetings with the pharmaceutical industry since December 1st 2019

Currently waiting for a response from Health and Food Safety, they should respond promptly and normally no later than (details).

Dear Health and Food Safety,

On behalf of Corporate Europe Observatory (CEO), I would like to - under the right of access to documents in the EU treaties as developed in Regulation 1049/2001 - request access to the following documents:

- all reports (and other notes) from meetings between DG SANTE and representatives of the pharmaceutical industry (companies as well as organisations such as EFPIA) from December 1st 2019 onwards. This should include the following companies: Bayer AG, Novartis International AG, Merck, GlaxoSmithKline, Amgen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, SANOFI, Pfizer Inc., AstraZeneca, Eli Lilly and Company, and MSD (Europe) Inc. (Merck Sharp & Dohme).

- all correspondence (including emails) between the DG SANTE and representatives of the pharmaceutical industry (companies as well as organisations such as EFPIA) from December 1st 2019 onwards.

- a list of all the above-mentioned documents (including dates, names of participants/senders/recipients and their affiliation, subject of meeting/correspondence)

Yours faithfully,
Olivier Hoedeman

on behalf of Corporate Europe Observatory (CEO)
Corporate Europe Observatory (CEO)
Rue d'Edimbourg 26,
1050 Brussels, Belgium

http://www.corporateeurope.org
Tel. +32 (0)2 893 0930
Mobile: +32 474 486545
EU Transparency Register ID Number: 5353162366-85

Health and Food Safety

1 Attachment

Dear Mr Hoedeman,

 

Thank you for your e-mail dated 14 January 2020. We hereby acknowledge
receipt of your application for access to documents, which was registered
on the same date  under reference number GestDem 2020/0261.

 

In accordance with Regulation (EC) No 1049/2001 regarding public access to
European Parliament, Council and Commission documents, your application
will be handled within 15 working days. The time limit will expire on 4
february 2020. In case this time limit needs to be extended, you will be
informed in due course.

 

You have lodged your application via the AsktheEU.org website. Please note
that this is a private third-party website which has no link with any
institution of the European Union. Therefore, the European Commission
cannot be held accountable for any technical issues or problems linked to
the use of this system.

 

Please note that the private third party running the AsktheEU.org website
is responsible and accountable for the processing of your personal data
via that website, and not the European Commission. For further information
on your rights, please refer to the third party’s privacy policy.

 

We understand that the third party running that website usually publishes
the content of applicants’ correspondence with the European Commission on
that website. This includes the personal data that you may have
communicated to the European Commission (e.g. your private postal
address).

 

Similarly, the third party publishes on that website any reply that the
Commission will send to the email address of the applicants generated by
the AsktheEU.org website.

 

If you do not wish your correspondence with the European Commission to be
published on the AsktheEU.org website, you can provide us with an
alternative, private e-mail address for further correspondence. In that
case, the European Commission will send all future electronic
correspondence addressed to you only to that private address.

 

 

Yours sincerely,

 

SANTE ACCESS TO DOCUMENTS

[1]cid:image001.gif@01D3FF48.374A49E0
European Commission
Health and Food Safety

 

References

Visible links